Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Incyte

Status

Conditions: Graft-versus-host Disease (GVHD)

Treatments: Drug: Ruxolitinib

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05722912

I 18424-22-02

Details and patient eligibility

About

To provide ruxolitinib through an expanded access to treat a single patient with cGVHD

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria